For instance, in Finland the reduction in the number of doctors enacted in the early 1990s to curb health spending resulted in a steep drop in the number of medical students, resulting in an insufficient number of doctors in the following years that is slowly being reversed (OECD, 2012a). Drug price controls usually fix a maximum price for drugs or set a cap on the profits of pharmaceutical firms. The vast majority of OECD countries apply some form of pharmaceutical price regulation (Paris etal.,